China-focused exchange-traded funds and stocks of Chinese companies listed on U.S. exchanges fell Friday, after U.S. President Donald Trump said he was planning to double the existing tariff on goods from China.
Elastic shares jumped Friday after the data analytics software provider reported better-than-expected earnings on strong demand for products related to artificial intelligence.
(Reuters) -CME Group said on Friday that it plans to roll out futures contracts on cryptocurrency Solana on March 17, pending regulatory review. The exchange said it expects to debut two contracts, one for 500 Solana coins and a "micro-sized" contract for 25 Solana. "We are responding to increasing client demand for a broader set of regulated products to manage cryptocurrency price risk," said Giovanni Vicioso, global head of cryptocurrency products at CME.
Bithumb, a prominent South Korean crypto exchange, has officially added Ethena (ENA) to its KRW market.
Walgreens downgraded, Cava Group upgraded: Wall Street's top analyst calls
Tariffs and uncertain consumer spending dampened Wall Street's enthusiasm for the retailer.
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 6.3%. This drop is a stark contrast from the S&P 500’s 5.1% gain.
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 1.7% over the past six months. This drop was disappointing since the S&P 500 climbed 5.1%.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.3%. This performance is a noticeable divergence from the S&P 500’s 5.1% return.